L. Franco-Luzón

Benefits of exercise and immunotherapy in a murine model of human non-small-cell lung carcinoma.

A. Lucia, Esther Martínez-Martínez, A. Martín-Ruiz, 2020, Exercise immunology review.

Systemic oncolytic adenovirus delivered in mesenchymal carrier cells modulate tumor infiltrating immune cells and tumor microenvironment in mice with neuroblastoma

L. Chesler, M. Ramírez, M. Tabasi, 2020, Oncotarget.

Patient-derived mesenchymal stem cells as delivery vehicles for oncolytic virotherapy: novel state-of-the-art technology

G. Melen, J. García-Castro, M. Ramírez, 2015, Oncolytic virotherapy.

Influence of carrier cells on the clinical outcome of children with neuroblastoma treated with high dose of oncolytic adenovirus delivered in mesenchymal stem cells.

R. Alemany, A. Alfranca, G. Melen, 2016, Cancer letters.

Genetic and Immune Changes Associated with Disease Progression under the Pressure of Oncolytic Therapy in A Neuroblastoma Outlier Patient

R. Sanz-Pamplona, G. Melen, Á. Lassaletta, 2020, Cancers.